Attorney General Kwame Raoul, in conjunction with a coalition of 50 attorneys general across the nation, has recently filed for preliminary approval of a $39.1 million settlement with pharmaceutical company Apotex Inc. The claim against the generic drug manufacturer revolves around allegations of price inflation and the stifling of competition within the industry. As reported by the Illinois Attorney General's office, Illinois residents who have purchased specific generic prescription drugs between May 2009 and December 2019 may be eligible to claim compensation as part of this settlement. The public can seek such eligibility information through a dedicated phone line, an email address, or a website set up to assist consumers.
The office of Raoul encourages constituents to proactively to check their eligibility, pointing out that this settlement is a further step in the government's effort to hold accountable those who allegedly pursue profit at the expense of consumers. “This settlement builds on the work my office is doing to hold drug companies accountable for engaging in practices to maximize profits at the expense of the health and pocketbooks of Illinoisans," Raoul said. "I will continue to stand with my fellow attorneys general to stop pharmaceutical companies and executives from being able to continue the unlawful and unfair tactics that fuel health care inequity around the country.” These comments reflect a commitment to addressing the broader issue of healthcare equity.
Following the collection of necessary signatures from states and territories, the Attorney General and his colleagues are submitting the settlement for approval in the U.S. District Court for the District of Connecticut. This comes after the announcement of the settlement in principle last October and a $10 million settlement reached with Heritage Pharmaceuticals. Under the agreements, both companies are required to cooperate with the ongoing multistate litigation that targets several other pharmaceutical companies and key executives. The settlement also calls for future preventive measures through injunctive relief and internal reforms to facilitate compliance with antitrust laws.
According to the investigation, these pharmaceutical companies were part of a systematic effort to artificially increase the prices of drugs, subvert competition, and unreasonably restrain trade. The alleged conspiracies included a variety of communication channels such as emails, texts, and even social gatherings where industry executives are said to have made illicit agreements. “Each complaint addresses a different set of drugs and defendants, and lays out an interconnected web of competing industry executives who met with each other during industry dinners, “girls’ nights out,” lunches, cocktail parties and golf outings, and communicated via frequent telephone calls, emails and text messages that laid the foundation for their illegal agreements,” stated the office of the Illinois Attorney General.
The coalition of state attorneys general that joined Raoul in the legal action represents a large majority of the United States, signaling a nationwide commitment to challenging alleged unlawful practices within the pharmaceutical industry.
